Percutaneous left atrial appendage closure with SeaLA device in non‐valvular atrial fibrillation
Catheterization and Cardiovascular Interventions · 2024
DOI: 10.1002/ccd.31056 ↗At a glance
Multizentrische Studie in Catheterization and Cardiovascular Interventions, 2024. Written by Zulu Wang and 16 co-authors. Institution: Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China. Major MEDLINE topics: Atrial Appendage, Atrial Fibrillation, Cardiac Catheterization, Prosthesis Design. 23 references. Funded by: Dinova EP Technology.
Abstract (original language)
Objectives
The clinical efficacy and safety of a novel left atrial appendage (LAA) occluder of the SeaLA closure system in patients with nonvalvular atrial fibrillation (NVAF) were reported.
Background
Patients with NVAF are at a higher risk of stroke compared to healthy individuals. Left atrial appendage closure (LAAC) has emerged as a prominent strategy for reducing the risk of thrombosis in individuals with NVAF.
Methods
A prospective, multicenter study was conducted in NVAF patients with a high risk of stroke.
Results
The LAAC was successfully performed in 163 patients. The mean age was 66.93 ± 7.92 years, with a mean preoperative CHA2DS2‐VASc score of 4.17 ± 1.48. One patient with residual flow >3 mm was observed at the 6‐month follow‐up, confirmed by TEE. During the follow‐up, 2 severe pericardiac effusions were noted, and 2 ischemic strokes were observed. Four device‐related thromboses were resolved after anticoagulation treatment. There was no device embolism.
Conclusions
The LAAC with the SeaLA device demonstrates encouraging feasibility, safety, and efficacy outcomes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China.
- Arrhythmia Center, Ningbo First Hospital, The First Affiliated Hospital of Ningbo University, Ningbo, China.
- Department of Cardiology, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China.
- Department of Cardiology, Xijing Hospital, Air Force Military Medical University, Xi'an, China.
- Department of Cardiology, The 7th People's Hospital of Zhengzhou, Henan Cardiovascular Hospital Affiliated to Southern Medical University, Zhengzhou, China.
- Department of Cardiology, Henan Provincial Chest Hospital, Zhengzhou, China.
ORCID profiles: Zulu Wang, Huimin Chu, Weijian Huang
Funding
- Dinova EP Technology
Cite
APA
Wang, Z., Chu, H., Chen, X., Tao, L., Yuan, Y., Ru, L., Wang, J., Fan, Y., Hu, H., Wang, C., Chen, M., Huang, W., Zhou, D., Liu, X., Liang, M., Liu, J., & Han, Y. (2024). Percutaneous left atrial appendage closure with SeaLA device in non‐valvular atrial fibrillation. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31056
Vancouver
Wang Z, Chu H, Chen X, Tao L, Yuan Y, Ru L, et al. Percutaneous left atrial appendage closure with SeaLA device in non‐valvular atrial fibrillation. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.31056
BibTeX
@article{Wang2024,
author = {Wang, Zulu and Chu, Huimin and Chen, Xinjing and Tao, Ling and Yuan, Yiqiang and Ru, Leisheng and Wang, Jianan and Fan, Youqi and Hu, Hongde and Wang, Changqian and Chen, Minglong and Huang, Weijian and Zhou, Daxin and Liu, Xingpeng and Liang, Ming and Liu, Jing and Han, Yaling},
title = {Percutaneous left atrial appendage closure with SeaLA device in non‐valvular atrial fibrillation},
journal = {Catheterization and Cardiovascular Interventions},
year = {2024},
doi = {10.1002/ccd.31056}
}
EUVIMED